Personalized Inhaled Bacteriophage Therapy Decreases Multidrug-Resistant Pseudomonas aeruginosa
Preprint in medRxiv (January 2023)
The most recent citing publications are shown below. View all 10 publications that cite this research output on Dimensions.
Challenges and opportunities in the development of novel antimicrobial therapeutics for cystic fibrosis.
Article in Journal of Medical Microbiology (December 2022)
Bacteriophage: A new therapeutic player to combat neutrophilic inflammation in chronic airway diseases
Article in Frontiers in Medicine (December 2022)